Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Mass Spectrometer

By Drug Discovery Trends Editor | March 9, 2009

The AccuTOF-GCv mass spectrometer from JEOL features high sensitivity. By combining rapid data acquisition speeds with high resolution and a high dynamic range, the AccuTOF-GCv delivers exact mass measurements for both qualitative and quantitative analysis, according to JEOL.

The AccuTOF-GCv introduces several new software features including automatic ion source tuning, automatic drift calibration, and automatic data file conversion and export.  The Tuning Assistant function optimizes ion source parameters for peak ion intensity and resolution.

In addition to the standard EI source and optional CI source, a new optional EI/FI/FD combination ion source eliminates the need to exchange ion sources to switch between electron impact and field ionization or field desorption ionization, resulting in higher sample throughput, easier operation, and longer uptime. The combination EI/FI/FD source also enables GC-FI operation that can be used to characterize samples that are difficult for traditional GC-EI or GC-CI measurements. The AccuTOF-GCv aids qualitative analysis using the mass spectra library search, polymer analysis, and hydrocarbon analysis. An optional comprehensive 2D GCxGC measurement attachment is available. 

The high sensitivity (S/N > 100 at OFN 1 pg/mL) of the AccuTOF-GCv allows for rapid exact mass and target compound identification and quantitation in trace analyses. The AccuTOF-GCv combines high-speed acquisition of 25 averaged spectra per second with high mass resolving power of 6000 FWHM and mass accuracy of 5 ppm — and it provides the highest linear dynamic range for improved analysis of both low and high concentrations, according to the company. 

www.jeolusa.com


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE